These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 29996199)

  • 1. [Clinical value of noninvasive method in diagnosing hepatic fibrosis about chronic HBV carriers].
    Zhang XY; Qian J; Li P; Hu LH; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):332-336. PubMed ID: 29996199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of FibroScan in liver fibrosis evaluation in patients with chronic hepatitis B virus infection and related influencing factors].
    Xie QX; Xu N; Jiang XP; Zhang YF; Zhang ZH; Li JB; Hu XY; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):659-664. PubMed ID: 27788721
    [No Abstract]   [Full Text] [Related]  

  • 4. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
    Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
    Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infection.
    Huang C; Li Q; Xu W; Wang Q; Hu Q; Zhang X; Huang Y; Chen L
    Discov Med; 2020; 29(157):119-128. PubMed ID: 33002408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients.
    Dong M; Wu J; Yu X; Li J; Yang S; Qi X; Mao R; Zhang Y; Yu J; Zhu H; Yang F; Qin Y; Zhang J
    Liver Int; 2018 Sep; 38(9):1562-1570. PubMed ID: 29314613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
    J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
    Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
    Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
    Zeng X; Xu C; He D; Li M; Zhang H; Wu Q; Xiang D; Wang Y
    Croat Med J; 2015 Jun; 56(3):272-9. PubMed ID: 26088852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.
    Sanai FM; Farah T; Albeladi K; Batwa F; Dahlan Y; Babatin MA; Al-Ashgar H; AlMana H; Alsaad KS; AlSwat K; Aljumah A; AlTraif IH; Kailani BE; Bzeizi KI
    BMC Gastroenterol; 2017 Aug; 17(1):101. PubMed ID: 28841822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver fibrosis by transient elastography and multi-parameters model in young children with chronic hepatitis B virus infection.
    Luo H; Peng S; Ouyang W; Tan Y; Jiang T; Tang L; Li S; Qiu J; Zhou C
    BMC Infect Dis; 2022 Feb; 22(1):160. PubMed ID: 35180839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum WFA
    Zou X; Zhu MY; Yu DM; Li W; Zhang DH; Lu FJ; Gong QM; Liu F; Jiang JH; Zheng MH; Kuno A; Narimatsu H; Zhang Y; Zhang XX
    Liver Int; 2017 Jan; 37(1):35-44. PubMed ID: 27300763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total serum bile acids predict therapy for HBeAg-negative chronic hepatitis B patients with borderline ALT and high HBV DNA.
    Xie R; Li J; Zhang H; Wang LM; Huang CR; Chen LW
    J Infect Dev Ctries; 2022 Aug; 16(8):1336-1342. PubMed ID: 36099378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.
    Zhang Z; Wang G; Kang K; Wu G; Wang P
    PLoS One; 2016; 11(4):e0152757. PubMed ID: 27050531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.
    Zhu X; Wang LC; Chen EQ; Chen XB; Chen LY; Liu L; Lei XZ; Liu C; Tang H
    Dig Dis Sci; 2011 Sep; 56(9):2742-9. PubMed ID: 21399926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease].
    Wang R; Ren W; Zhao S; Niu X; Tan P; Du H; Nan Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):265-9. PubMed ID: 26133817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
    Mohamadnejad M; Montazeri G; Fazlollahi A; Zamani F; Nasiri J; Nobakht H; Forouzanfar MH; Abedian S; Tavangar SM; Mohamadkhani A; Ghoujeghi F; Estakhri A; Nouri N; Farzadi Z; Najjari A; Malekzadeh R
    Am J Gastroenterol; 2006 Nov; 101(11):2537-45. PubMed ID: 17029616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.